Regional Account Manager-Neurology (Upper Mid West based Candidates)
Axsome Therapeutics IncSalary not specified
- Full Time
- Junior (1 to 2 years)
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, PharmaceuticalsIndustries
Requirements
Candidates are required to possess a Bachelor's degree and a minimum of 5 years of experience in biotech or pharmaceutical sales, with preference given to territory ownership experience and prior experience in cardiology, rare diseases, or specialty products. Knowledge of rare disease markets and specialty product launches is also preferred.
Responsibilities
As a Cardiovascular Account Specialist, you will be responsible for introducing Cytokinetics within your territory and launching its first commercial product, a novel cardiac myosin inhibitor for Hypertrophic Cardiomyopathy (HCM). This includes developing territory-specific account plans, identifying and developing strategic IDNs and hospitals, establishing yourself as a resource within care settings, communicating approved resources to HCPs, and demonstrating strategic thinking while supporting the Company’s Mission to address patients’ unmet needs.
Skills
Biotech Sales
Pharmaceutical Sales
Cardiology
Rare Disease
Specialty Product Launch
Account Planning
Territory Management
Customer Relationship Building
Disease and Product Knowledge
Cytokinetics
Develops drugs for muscle function disorders
About Cytokinetics
Cytokinetics focuses on developing medicines that improve muscle function for patients with cardiovascular and neuromuscular diseases. Their products are small molecule drugs designed to either enhance or inhibit muscle function, tailored to specific therapeutic needs. The company has a pipeline of drugs, including omecamtiv mecarbil and reldesemtiv, which are in various stages of clinical trials. Unlike many competitors, Cytokinetics emphasizes rigorous scientific research and has conducted over 50 clinical trials to ensure the effectiveness of its treatments. The goal is to bring new therapies to market that address the unmet needs of patients suffering from conditions like heart failure, ALS, and HCM.
Key Metrics
South San Francisco, CaliforniaHeadquarters
1998Year Founded
$58.4MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
501-1,000Employees